{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:34:47Z","timestamp":1791308087679,"version":"4.3.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.jaci.2011.08.029","type":"journal-article","created":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T14:16:29Z","timestamp":1317478589000},"page":"501-509.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Uptake of blood coagulation factor VIII by dendritic cells is mediated via its C1 domain"],"prefix":"10.1016","volume":"129","author":[{"given":"Eszter","family":"Herczenik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon D.","family":"van Haren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Wroblewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kaijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maartje","family":"van den Biggelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander B.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Martinez-Pomares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"ten Brinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Voorberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2011.08.029_bib1","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM200106073442307","article-title":"The hemophilias\u2014from royal genes to gene therapy","volume":"344","author":"Mannucci","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.08.029_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood-2008-06-160432","article-title":"How we treat a hemophilia A\u00a0patient with a factor VIII inhibitor","volume":"113","author":"Kempton","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.08.029_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-2003-37940","article-title":"Immunobiology of inhibitor development in hemophilia A","volume":"29","author":"Fijnvandraat","year":"2003","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jaci.2011.08.029_bib4","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1538-7836.2004.00802.x","article-title":"Pathogenic antibodies to coagulation factors, Part one: factor VIII and factor IX","volume":"2","author":"Lollar","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jaci.2011.08.029_bib5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1538-7836.2007.02474.x","article-title":"Immune tolerance therapy for factor VIII inhibitors: moving from empiricism to an evidence-based approach","volume":"5","author":"Dimichele","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jaci.2011.08.029_bib6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1055\/s-0037-1614081","article-title":"Sensitization of CD4+ T cells to coagulation factor VIII: response in congenital and acquired hemophilia patients and in healthy subjects","volume":"84","author":"Reding","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaci.2011.08.029_bib7","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2141.2008.07232.x","article-title":"IgG subclasses of anti-FVIII antibodies during immune tolerance induction in patients with hemophilia A","volume":"142","author":"van Helden","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2011.08.029_bib8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood.V92.2.496","article-title":"Mechanism and kinetics of factor VIII inactivation: study with an IgG4 monoclonal antibody derived from a hemophilia A\u00a0patient with inhibitor","volume":"92","author":"Jacquemin","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.08.029_bib9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1182\/blood.V96.2.540.014k20_540_545","article-title":"Molecular analysis of human anti-factor VIII antibodies by V gene phage display identifies a new epitope in the acidic region following the A2 domain","volume":"96","author":"van den Brink","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.08.029_bib10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/381751a0","article-title":"Clonal selection and learning in the antibody system","volume":"381","author":"Rajewsky","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2011.08.029_bib11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1182\/blood-2008-02-124941","article-title":"Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A","volume":"112","author":"Lacroix-Desmazes","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.08.029_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nri746","article-title":"Mouse and human dendritic cell subtypes","volume":"2","author":"Shortman","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2011.08.029_bib13","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/j.1538-7836.2009.03571.x","article-title":"Splenic marginal zone antigen-presenting cells are critical for the primary allo-immune response to therapeutic factor VIII in hemophilia A","volume":"7","author":"Navarrete","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jaci.2011.08.029_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1160\/TH05-11-0729","article-title":"Recombinant factor VIII and factor VIII-von Willebrand factor complex do not present danger signals for human dendritic cells","volume":"96","author":"Pfistershammer","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaci.2011.08.029_bib15","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1111\/j.1538-7836.2008.03165.x","article-title":"Reduction of the immune response to factor VIII mediated through tolerogenic factor VIII presentation by immature dendritic cells","volume":"6","author":"Qadura","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jaci.2011.08.029_bib16","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1073\/pnas.0702120104","article-title":"A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytes","volume":"104","author":"Dasgupta","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2011.08.029_bib17","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1021\/ac970372z","article-title":"Structural characterization of site-specific N-glycosylation of recombinant human factor VIII by reversed-phase high-performance liquid chromatography-electrospray ionization mass spectrometry","volume":"69","author":"Medzihradszky","year":"1997","journal-title":"Anal Chem"},{"key":"10.1016\/j.jaci.2011.08.029_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-065X.2009.00786.x","article-title":"Endogenous ligands for C-type lectin receptors: the true regulators of immune homeostasis","volume":"230","author":"Garcia-Vallejo","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2011.08.029_bib19","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1182\/blood-2002-07-2081","article-title":"Elevated plasma factor VIII in a mouse model of low-density lipoprotein receptor-related protein deficiency","volume":"101","author":"Bovenschen","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.08.029_bib20","doi-asserted-by":"crossref","first-page":"23734","DOI":"10.1074\/jbc.274.34.23734","article-title":"The light chain of factor VIII comprises a binding site for low density lipoprotein receptor-related protein","volume":"274","author":"Lenting","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2011.08.029_bib21","doi-asserted-by":"crossref","first-page":"37685","DOI":"10.1074\/jbc.274.53.37685","article-title":"Role of the low density lipoprotein-related protein receptor in mediation of factor VIII catabolism","volume":"274","author":"Saenko","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2011.08.029_bib22","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1182\/blood.V97.4.966","article-title":"Multiple VH genes are used to assemble human antibodies directed toward the A3-C1 domains of factor VIII","volume":"97","author":"van den Brink","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.08.029_bib23","doi-asserted-by":"crossref","first-page":"9370","DOI":"10.1074\/jbc.M212053200","article-title":"Low density lipoprotein receptor-related protein and factor IXa share structural requirements for binding to the A3 domain of coagulation factor VIII","volume":"278","author":"Bovenschen","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2011.08.029_bib24","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/j.1538-7836.2006.01965.x","article-title":"Proteolytic cleavage of factor VIII heavy chain is required to expose the binding-site for low-density lipoprotein receptor-related protein within the A2 domain","volume":"4","author":"Bovenschen","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jaci.2011.08.029_bib25","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M110.002246","article-title":"HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII","volume":"10","author":"van Haren","year":"2011","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jaci.2011.08.029_bib26","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1182\/blood.V99.8.2828","article-title":"Two classes of germline genes both derived from the V(H)1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIII","volume":"99","author":"van den Brink","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.08.029_bib27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1365-2141.2001.02752.x","article-title":"Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis","volume":"113","author":"Amini-Nekoo","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2011.08.029_bib28","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1182\/blood-2009-01-197707","article-title":"Factor VIII C1 domain residues Lys 2092 and Phe 2093 contribute to membrane binding and cofactor activity","volume":"114","author":"Meems","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.08.029_bib29","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/eji.200535685","article-title":"Carbohydrate-independent recognition of collagens by the macrophage mannose receptor","volume":"36","author":"Martinez-Pomares","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2011.08.029_bib30","doi-asserted-by":"crossref","first-page":"39484","DOI":"10.1074\/jbc.M104382200","article-title":"Recognition of alpha 2-macroglobulin by the low density lipoprotein receptor-related protein requires the cooperation of two ligand binding cluster regions","volume":"276","author":"Mikhailenko","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2011.08.029_bib31","doi-asserted-by":"crossref","first-page":"v9","DOI":"10.1093\/ndt\/gfl476","article-title":"Immunogenicity of biopharmaceuticals","volume":"21","author":"Kessler","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jaci.2011.08.029_bib32","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1182\/blood-2006-11-056291","article-title":"Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study","volume":"109","author":"Gouw","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.08.029_bib33","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1538-7836.2009.03346.x","article-title":"Molecular mechanisms underlying hemophilia A\u00a0phenotype in seven females","volume":"7","author":"Pavlova","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jaci.2011.08.029_bib34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1182\/blood-2008-04-151597","article-title":"Anti-CD3 prevents factor VIII inhibitor development in hemophilia A\u00a0mice by a regulatory CD4+CD25+-dependent mechanism and by shifting cytokine production to favor a Th1 response","volume":"113","author":"Waters","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.08.029_bib35","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nri1669","article-title":"Structure and function of the spleen","volume":"5","author":"Mebius","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2011.08.029_bib36","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1182\/blood-2004-11-4230","article-title":"LDL receptor cooperates with LDL receptor-related protein in regulating plasma levels of coagulation factor VIII in\u00a0vivo","volume":"106","author":"Bovenschen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.08.029_bib37","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.bbapap.2007.04.003","article-title":"Functional duplication of ligand-binding domains within low-density lipoprotein receptor-related protein for interaction with receptor associated protein, alpha2-macroglobulin, factor IXa and factor VIII","volume":"1774","author":"Meijer","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaci.2011.08.029_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3324\/haematol.11535","article-title":"Factor VIII bypasses CD91\/LRP for endocytosis by dendritic cells leading to T-cell activation","volume":"93","author":"Dasgupta","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.jaci.2011.08.029_bib39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.coi.2007.12.002","article-title":"Endocytosis mechanisms and the cell biology of antigen presentation","volume":"20","author":"Burgdorf","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2011.08.029_bib40","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0092-8674(80)90402-X","article-title":"Receptor-mediated pinocytosis of mannose glycoconjugates by macrophages: characterization and evidence for receptor recycling","volume":"19","author":"Stahl","year":"1980","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2011.08.029_bib41","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/hq0302.105359","article-title":"Phospholipid-binding domain of factor VIII is involved in endothelial cell-mediated activation of factor X by factor IXa","volume":"22","author":"Brinkman","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jaci.2011.08.029_bib42","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2141.2008.07232.x","article-title":"IgG subclasses of anti-FVIII antibodies during immune tolerance induction in patients with hemophilia A","volume":"142","author":"van Helden","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2011.08.029_bib43","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/j.1538-7836.2007.02737.x","article-title":"Requirements for cellular co-trafficking of factor VIII and von Willebrand factor to Weibel-Palade bodies","volume":"5","author":"van den Biggelaar","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jaci.2011.08.029_bib44","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/1521-4141(200106)31:6<1857::AID-IMMU1857>3.0.CO;2-D","article-title":"Endogenous ligands of carbohydrate recognition domains of the mannose receptor in murine macrophages, endothelial cells and secretory cells: potential relevance to inflammation and immunity","volume":"31","author":"Linehan","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2011.08.029_bib45","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/eji.200535685","article-title":"Carbohydrate-independent recognition of collagens by the macrophage mannose receptor","volume":"36","author":"Martinez-Pomares","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2011.08.029_bib46","doi-asserted-by":"crossref","first-page":"31305","DOI":"10.1074\/jbc.274.44.31305","article-title":"The second and fourth cluster of class A\u00a0cysteine-rich repeats of the low density lipoprotein receptor-related protein share ligand-binding properties","volume":"274","author":"Neels","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2011.08.029_bib47","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.bbapap.2007.04.003","article-title":"Functional duplication of ligand-binding domains within low-density lipoprotein receptor-related protein for interaction with receptor associated protein, alpha2-macroglobulin, factor IXa and factor VIII","volume":"1774","author":"Meijer","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaci.2011.08.029_bib48","doi-asserted-by":"crossref","first-page":"9370","DOI":"10.1074\/jbc.M212053200","article-title":"Low density lipoprotein receptor-related protein and factor IXa share structural requirements for binding to the A3 domain of coagulation factor VIII","volume":"278","author":"Bovenschen","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2011.08.029_bib49","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1182\/blood.V99.8.2828","article-title":"Two classes of germline genes both derived from the V(H)1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIII","volume":"99","author":"van den Brink","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.08.029_bib50","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1182\/blood-2009-01-197707","article-title":"Factor VIII C1 domain residues Lys 2092 and Phe 2093 contribute to membrane binding and cofactor activity","volume":"114","author":"Meems","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.08.029_bib51","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ng0595-119","article-title":"Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A","volume":"10","author":"Bi","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2011.08.029_bib52","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1182\/blood.V88.9.3446.bloodjournal8893446","article-title":"Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies","volume":"88","author":"Bi","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.08.029_bib53","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1055\/s-0037-1614401","article-title":"Phenotypic expression of murine hemophilia","volume":"82","author":"Muchitsch","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaci.2011.08.029_bib54","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1055\/s-0037-1614124","article-title":"Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A","volume":"84","author":"Reipert","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaci.2011.08.029_bib55","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1182\/blood.V95.4.1324.004k25_1324_1329","article-title":"Prevention and treatment of factor VIII inhibitors in murine hemophilia A","volume":"95","author":"Qian","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.08.029_bib56","doi-asserted-by":"crossref","first-page":"7145","DOI":"10.1016\/j.vaccine.2007.07.031","article-title":"The clinical grade maturation cocktail monophosphoryl lipid A\u00a0plus IFNgamma generates monocyte-derived dendritic cells with the capacity to migrate and induce Th1 polarization","volume":"25","author":"Ten Brinke","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2011.08.029_bib57","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0022-1759(01)00563-4","article-title":"Construction and characterization of affibody-Fc chimeras produced in Escherichia coli","volume":"261","author":"Ronnmark","year":"2002","journal-title":"J Immunol Methods"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911013959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911013959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:32:06Z","timestamp":1758789126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674911013959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0091674911013959"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2011.08.029","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uptake of blood coagulation factor VIII by dendritic cells is mediated via its C1 domain","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2011.08.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}